Lanean...
Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis
Although clinical outcomes for patients with rheumatoid arthritis (RA) have greatly improved with the use of biologic and conventional DMARDs, approximately 40% of patients do not achieve primary clinical outcomes in randomized trials, and only a small proportion achieve lasting remission. Over the...
Gorde:
| Argitaratua izan da: | Nat Rev Rheumatol |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475908/ https://ncbi.nlm.nih.gov/pubmed/29323343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrrheum.2017.205 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|